Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-24 @ 6:50 PM
NCT ID:
NCT05011357
Eligibility Criteria:
Inclusion Criteria:
* 18 to 45 years of age
* Non-obese (Body Mass Index less than 30 kg/m2)
* Baseline systolic blood pressure between 80-140 mmHg
* Baseline diastolic blood pressure \<90 mmHg
Exclusion Criteria:
* Participants who have cardiac, vascular, respiratory, neurological and/or metabolic illness
* Current or previous use of anti-hypertensive medications
* Any known history of renal or hepatic insufficiency/disease
* Pregnancy (verified by negative urine test on the experimental days) or breast-feeding
* Current smokers, as well as individuals who regularly smoked within the past 3 years
* Sulfite allergy, as this is a contraindication to intravenous phenylephrine
* Serious mental illness including claustrophobia
* History of use of recreational drugs including cocaine or amphetamines
* Peripheral vascular disease
* Subject on anticoagulant treatment
* Subjects with a baseline systolic blood pressure \<80 mmHg
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT05011357
Study Brief:
Protocol Section:
NCT05011357